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 Introduction: After treating the tooth root canal, pain is one of the problems that many patients are 
facing. In order to reduce pain, and regarding the advice of treating necrotic teeth during several 
sessions, intra-canal medicaments can be used between sessions. The purpose of this study is to 
compare pain relieving effect of calcium hydroxide combined with three solutions of normal saline, 
chlorhexidine 2% and dexamethasone. Materials and methods: This triple blind randomized clinical 
trial was performed on 90 necrotic molars and premolars. The patients were classified in three 
medicaments' groups including mixture of calcium hydroxide and normal saline (G1), chlorhexidine 
2% (G2) or dexamethasone (G3) that were placed in the canal during the first treatment session. 
The patients were provided with a Heft-Parker Visual Analog Scale form to record their pain in 
different intervals of 4, 24, 48, 72 and 96 h after cleaning and shaping the root canal. Data analysis 
was carried out using the Chi-Square, one-way ANOVA and Repeated Measure tests. Results: No 
significant difference was observed in the mean pain of the groups after 4 h (P>0.05). However, a 
significant difference was found between G1 and G3 in the mean pain from day 1 to 72 h after 
treatment. The mean pain was less in dexamethasone (G3) group (P<0.05), but the difference was 
not statistically significant at 96 h after treatment (P>0.05). No significant difference was found 
between "G2-G1" and "G2-G3" groups at different time intervals (P>0.05). Conclusion: The mixture 
of calcium hydroxide and dexamethasone compared to calcium hydroxide and normal saline in 
short and medium time had a significant effect on reducing pain after cleaning and shaping the root 
canal. It seems that the mixture of calcium hydroxide and dexamethasone can be considered as an 
effective medicament on reducing pain during root canal treatment sessions. 
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Introduction 
ain is common during an individual's life as an unpleasant 
sense. Dental treatments are often associated with pain [1-4]. 
Despite recent advances in pain management [5], in studies, pain 
has been reported with a prevalence of 2.53 to 58% [6, 7] 
indicating that post-endodontic pain continues to be highly 
prevalent. 
Various factors have been identified for endodontic pain, 
including pre-treatment inflammatory conditions, or 
development of periapical root canal and degeneration of pre-
apex zone. The severity of pain is also related to genetics, patient's 
immune status, infection and rate of tissue degeneration, one of 
the predictive factors for pain after treatment is asymptomatic 
necrotic pulp with a periodontal lesion [8-15]. 
Considering the advice of treating during several sessions for 
teeth with non-vital pulp, intra-canal medicaments can be used 
for different purposes, such as reducing the amount of bacteria or 
inflammatory agents. In teeth with necrotic pulp, it is agreed that 
these teeth are more resistant to endodontic treatment and may 
require several sessions of endodontic treatment and as a result, 
for treating during several sessions, an antimicrobial dressing 
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could be applied for approximately one week between sessions 
and inside the canal to maximize antimicrobial activity [16, 17]. 
Today, calcium hydroxide (CH) is considered as one of the most 
effective intra-canal medicaments in endodontic treatment because 
of its alkalinity and antimicrobial properties [18, 19]. However, 
meta-analyzes did not show a significant effect on pain relief [20]. 
Chlorhexidine is also one of the intra-canal irrigant that affects 
many gram positive and negative bacterial species [21, 22]. 
Another medicament used to reduce endodontic pain in 
different ways is corticosteroids family. The use of corticosteroids 
was criticized by Sinkford and Harris on 1964 [23] and Klotz on 
the following year [24]. They claimed that although the use of 
corticosteroids inhibits hyperemia or inflammation in vital teeth, 
it also has systemic complications, which was rejected by Abbot 
on 1992 [25]. Other recent studies did not report any specific side 
effects for this category [3, 26]. Although some recent studies 
claim that assumption of corticosteroids is effective for 
endodontic pain management [27, 28], however, due to the 
variety of intervention types or different methods of procedural 
unity, there is no evidence of the effect of corticosteroids on the 
reduction of endodontic pain [29, 30]. 
Therefore, the purpose of this study is to investigate the effect 
of pain relief with medicaments of 1-calcium hydroxide and 
normal saline 0.9% (G1), 2-calcium hydroxide and chlorhexidine 
2% (G2) and 3-calcium hydroxide and dexamethasone 8 mg/2 mL 
(G3) during treatment sessions in the root canal of necrotic 
molars and premolars. 
Methods and materials 
This study was a triple blind clinical trial approved by Aja 
University of Medical Sciences Ethics Committee, Tehran, Iran 
(IR.AJAUMS.REC.1397.005), as well as registered at the Iranian 
Center for Clinical Trials Registration www.irct.ir 
(IRCT20180521039766N1), on a total of 90 necrotic molars and 
premolars referred to the dentist. 
The number of patients was obtained using software Med 
Calc. version 7.5 (Mariakerke Belgium); the test error was 5% 
and the test power was 80% [31]. According to Cochran formula, 
the sample size was estimated n=85 and by considering the 
division of patients into three groups, the total of 90 patients (30 
patients in each group) were examined, otherwise putting 
patients in each group randomized and continued until it 
reached the aforementioned limit. 
 
Table 1. Demographic information including the patients' gender, teeth type and age  
N (%) CH+Normal saline  CH+Chlorhexidine  CH+Dexamethasone  Total  P-value***  
Gender* 
Male 17 (56.7) 11 (36.7) 12 (40) 40 (44.4) 0.248 
Female 13 (43.3) 19 (63.3) 18 (60) 50 (55.6) 
Teeth type* 
Molar 25 (83.3) 26 (86.7) 23 (76.7%) 74 (72.2) 
0.587 Pre Molar 5 (16.7) 4 (13.3) 7 (23.3%) 16 (17.8) 
Total 30 (33.3) 30 (33.3) 30 (33.3) 90 (100) 
Age** Mean (SD) 27.90 (11.868) 25.90 (10.240) 29.47 (13.048) 27.76 (11.734) 0.504 
* Amount (%), Chi- Square test; **Mean (SD), one- way ANOVA; *** The mean difference is significant at the 0.05 level 
 
Table 2. The number of individuals with comparing the significance of the mean pain between the groups at different intervals  
N (%)  None* Mild* Moderate* Severe* Tukey test P-Value 
4 h  
G1 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
Not significant between groups 0.665 G2 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
G3 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
24 h  
G1 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) G1 and G3 
G1: 34.67±51.443 
G3: 7.87±24.126 
0.019** G2 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
G3 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
48 h  
G1 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) G1 and G3 
G1: 29.50±40.905 
G3: 6.17±30.981 
0.035** G2 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
G3 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
72 h  
G1 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) G1 and G3 
G1: 16.63±39.406 
G3: 0.67±2.537 
0.028** G2 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
G3 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
96 h  G1 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) Not significant between groups 0.161 
G2 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 
 
IEJ Iranian Endodontic Journal 2019;14(1): 1-6 
3 Effect of different CH intra-canal medicaments on endodontic pain 
G3 14 (46.7) 13 (43.3) 2 (6.7) 1 (3.3) 






























Figure 1. Flow-chart diagram of the study design 
 
The study inclusion criteria included the absence of any 
systemic disease, necrotic molar or permanent premolar with 
closed apex, lack of any kind of resorption, non-use of 
antibiotics and pre-treatment analgesics; and the study 
exclusion criteria included no referral for continued treatment, 
patient's unwillingness to co-operate, not registering pain in the 
relevant form, pregnancy, non-restorable teeth, allergy to 
analgesics, suffering from a systemic disease and a history of 
chronic use of analgesics, drugs or alcohol. 
In the first treatment session, after obtaining informed 
consent and performing vitality tests to confirm the necrotic 
condition, anesthesia was performed with lidocaine 2% plus 
epinephrine 1:80.000 (Daroopakhsh, Tehran, Iran) as an 
infiltration injection for maxillary teeth and block injection of 
inferior alveolar nerve for mandibular teeth. After ensuring 
anesthesia, the teeth were isolated by rubber dam and after 
providing the access cavity, the length was determined using apex 
locator Root ZX (Morita Corporation, Japan), 1 mm less than the 
apex mark of the device, also re-checked by periapical 
radiography. Finally, cleaning and shaping were done by step back 
method and with handy K-files (Mani, Togichi, Japan). 
The patients were categorized by an assistant according to 
random numbers Table. The dentist, patient and statistical analyst 
did not know the groups. Three different medicaments including 
CH (Golchai, Iran) with chlorhexidine 2% (Maquira, Brazil), 
dexamethasone 8 mg/2 mL (Caspian, Iran) or normal saline 0.9% 
(Samen, Iran) were prepared by an assistant with the same module 
and proportion for patients (0.12 g powder plus 0.14 mL liquid) 
on a glass slab and provided to the dentist. It was placed in the 
canal with lentulo (Thomas, France) for one week, and the tooth 
Excluded (n=106) 
• Not meeting inclusion criteria (n=68 ) 
• Declined to participate (n=15) 
• Other reasons (n=23) 
Analysed (n=30) 
Lost to follow-up (VAS form not 
received) (n=2) 
Discontinued intervention (n=0) 
G1: 
•  Received allocated intervention (n= 32)  
G2: 




Assessed for eligibility (n=205) 
Randomized (n=99) 
G3: 
•  Received allocated intervention (n=33)  
Lost to follow-up (VAS form not 
received) (n=3) 
Discontinued intervention (financial 
issues) (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (financial 
issues) (n=3) 
Analysed (n=30) Analysed (n=30) 
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was dressed with Cavisol (Golchai, Iran).  
The patients were provided with a pain registration form 
based on the Heath-Parker VAS (Visual Analog Scale) to record 
their pain at different intervals of 4, 24, 48, 72 and 96 h after  
 
 
Figure 2. The mean (SD) of pain in treatment groups 
 
cleaning and shaping of the root canal. In the second session, the 
patients referred in order to complete the root canal treatment.  
The forms presented to the patients included a scale of 0 to 170 
mm such that 0 mm was related to no pain, 1-54 mm was related to 
mild pain, 55-113 mm was related to moderate pain and 114-170 
was related to severe pain. Meanwhile, the patients were asked to 
record the amount of their used analgesics by the fourth day. 
The collected data were analyzed by SPSS software version 23 
(SPSS Inc., Chicago, US). The Chi-Square test were used to assess 
the demographic variables of gender and type of teeth in the groups. 
The One-way ANOVA was used to examine the difference between 
the mean age and level of analgesics consumption in groups, as well 
as the comparison of mean pain at different time intervals. 
Tukey’s post hoc were used for pair wise group comparisons. In 
order to compare the effect of three medicaments, as well as the 
effect of time on the treatment, we used repeated measures analysis 
of variance. Data was presented in the form of time-dependent 
figures and tables of pain-demographic measurements. The 
significance level for the tests was considered 0.05. 
Results 
Totally 99 patients had the study inclusion criteria, 4 patients (4.0%) 
were excluded due to reasons such as economic issues and 5 patients 
(5.0%) due to failure to complete or give back pain registration form 
(Figure 1). 
The remaining 90 patients were 40 men (44.4%) and 50 women 
(55.6%) with the mean age of 27.76±11.734 (min 15 and max 65 
years) in three different groups with 30 patients. Demographic 
variables of the patients are presented in Table 1. The Chi-Square 
test revealed that no significant difference was found between 
gender and tooth types in the groups (P>0.05). Also the One-way 
ANOVA also showed that no significant difference was found 
between the groups in terms of mean age (P>0.05). Also, no 
significant difference was found between the groups in terms of 
four-day mean of analgesics consumption (1.36 ± 2.432) (P>0.05) 
(Table 1). 
Numbers and percentages of those who have reported different 
pain rates at different time intervals have been reported in Table 2. 
Analysis of one-way ANOVA showed that in the first 4 h after the 
first session of treatment and 96 h after that, the mean pain reported 
was not significant between the groups (P>0.05). Tukey post hoc 
showed a significant difference in terms of mean pain at 24,48 and 
72 h after the first session of treatment between the groups of CH 
and normal saline (G1) and CH and dexamethasone (G3) (P<0.05), 
and the mean pain was lower in dexamethasone group (Table 2). 
Figure 2 compares and shows the mean of the reported pain in the 
three treatment groups and in relation to time. 
Repeated measures analysis of variance showed that the 
treatment between the groups as well as the effect of time and 
treatment was significant (P<0.05). 
Discussion 
This triple blind clinical trial reviewed pain relieving effect of 
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with necrotic pulp. It seems that a mixture of CH and 
dexamethasone was more effective than the other medicaments 
since the first 3 days. Although in the long run the amount of 
pain was still minimal with dexamethasone mixture and had the 
lowest mean pain, but after four days no significant difference 
was observed in the groups.  
Although previous studies have already shown pain relieving 
effect of CH, some theoretical studies contradicted no effect of 
calcium hydroxide [32-34], and on the same hand a review study 
also concluded that CH had no significant effect on pain relief [20]. 
Some studies have also compared the effects of corticosteroids 
and calcium hydroxide [35-37]. In a systematic review study that 
investigated pain relieving effect of corticosteroids on post-
operative pain, Iranmanesh et al. [29] stated due to the fact that 
studies that did not report the negative results of corticosteroids' 
effect on pain reliving were not published and also because of the 
difference in the study methods, it was not possible to conclude 
and accurately evaluate the effect of corticosteroids on pain relief. 
Accordingly, no specific dose of corticosteroids has been 
proposed. However, they stated that the intra-canal dose can be 
safe and effective [29]. 
Gama et al. [38] in their study on 138 asymptomatic teeth 
compared the effect of CH and chlorhexidine on post-operative 
pain and concluded that no significant difference was found 
between the groups at each of the intervals [38]. 
Therefore, in this study, the mixture of CH powder with 
solutions of normal saline, 2% chlorhexidine and dexamethasone to 
reduce pain after the root canal treatment were compared. The 
results showed that, except for the 4th h and 4th day after treatment, 
the group with CH mixed with dexamethasone significantly 
reduced pain compared to CH and normal saline group, although 
no significant difference was found at all intervals of the 
chlorhexidine group in terms of pain reliving in comparison with 
dexamethasone or normal saline groups. 
In the study by Moskow et al. [39] which was conducted on 55 
vital teeth, dexamethasone and saline were used as the final rinsing 
solution, as in the present study, they showed a significant 
difference between 24 and 48 h, and within 72 h no significant 
difference was observed between the groups [39], which is 
inconsistent with this study, which could be due to the durability or 
effect of the paste state of the mixture of CH and the medicaments 
in the present study in comparison with their study or it may be due 
to the difference in vitality state of the teeth in the studies.  
The study by Ehrmann et al. [40] examined the effect of 
Ledrmix corticosteroid medicaments compared to calcium 
hydroxide paste or the absence of medicaments in the root canal of 
223 non-vital teeth. They acknowledged that after 4 hours, a 
significant difference was observed between the groups in terms of 
pain before treatment and until the 4th day, pain reduction was 
significant compared to the two other groups. The difference in the 
results of the fourth hour may be due to the difference in the type of 
corticosteroid and use of antimicrobials such as EDTA and NaOCl 
in the study for the canal rinsing, which can be considered as a 
confounding factor [40]. 
Rogers et al. [41], who compared pain relief of intra-canal forms 
of ketorolac, dexamethasone, ibuprofen and placebo on 48th 
maxillary teeth, reported no significant difference in the first 6 
hours after treatment [41]. Iranmanesh et al. [29] also in their 
review concluded that the greatest effect of corticosteroids was at 
35-48 hours after the treatment [29] which was consistent with the 
present study. 
The present study is consistent with the study by Gama et al. 
[38] as well as Hepsenoglu et al. [42] which compared the relieving 
effect of CH and 2% chlorhexidine gel on 150 asymptomatic teeth 
that needed to be re-treated. 
One of the limitations of this study is the difficulty of the study 
inclusion criteria in the referred population, and it is suggested that 
in future studies, different corticosteroids' doses should be studied 
with each other according to their post-treatment pain relief. 
Conclusion: 
Under the conditions of this study, and in patients with necrotic 
pulp, it seems that the combination of calcium hydroxide and 
dexamethasone can be considered as an effective medicament on 
reducing pain during the root canal treatment sessions. 
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